Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Transplant rejection averted by simple light exposure in Stanford animal study

06.05.2004


One of the unfortunate side effects of bone marrow and stem cell transplantation is that the newly implanted cells often stage an internal attack against the patient they’re intended to help. Stanford University School of Medicine researchers now have a better grasp of this phenomenon, known as graft-versus-host disease, or GVHD, and have proposed a possible method of prevention: simple ultraviolet light.



In a new animal study, researchers identified the principal culprit in GVHD: an immune cell in the skin known as a Langerhans cell. These cells normally function as flag posts for the immune system, signaling infection-fighting T-cells to come to a particular site to fight off a virus or bacteria. But in transplants, they do patients a great disservice, alerting T-cells to attack the patient’s own tissues, researchers found.

The researchers were able to effectively eliminate the Langerhans cells in transplanted mice by exposing them to ultraviolet light, giving the animals mild sunburn. Transplanted mice that received this treatment experienced no GVHD while those that didn’t showed severe signs of the disease, said Edgar Engleman, MD, professor of pathology and medicine and senior author of the study.


"The experiment not only provided the proof that these cells cause graft-versus-host disease, but also provides a way of thinking about how you might prevent it," said Engleman, who also directs the Stanford Blood Center. The study appears in the May issue of the journal Nature Medicine.

Bone marrow or stem cell transplants are commonly used to treat patients with cancers of the blood system, such as leukemia, lymphoma or myeloma. Patients first receive radiation treatment to wipe out their defective immune systems, which then are replaced by healthy donor cells.

Sometimes, however, the process fails as GVHD sets in. The effects of the disease are most commonly seen in the skin as a reddish rash or, in more severe cases, as skin that blisters and peels.

The Stanford scientists first suspected that Langerhans cells might have a major role in GVHD after their earlier experiments showed these cells were resistant to radiation and persisted in the skin for a long time, said Miriam Merad, MD, PhD, a former postdoctoral scholar in Engelman’s lab and the first author of the study. The discovery was "shocking," Engleman said, as all other white blood cells have a short half-life and are frequently replaced. The Langerhans cells don’t change unless they’re disturbed in some way, say by inflammation, he said.

The scientists surmised that these cells might linger in the skin of a transplant patient and instigate trouble. Their latest experiments bore this out.

The researchers tested their theory in two different sets of mice. In one group, the animals had their own Langerhans cells intact. When these animals were transplanted, the Langerhans cells triggered a response and the mice developed severe GVHD. In a second group, the scientists replaced the animals’ Langerhans cells with other cells. When these mice underwent transplant, they remained protected from GVHD.

The scientists took it a step further. They exposed the vulnerable mice - those with their own Langerhans cells - to ultraviolet light using a sunlamp. The sun exposure depleted the Langerhans cells and effectively protected the mice from the disease, said Merad, who is now based at the Mount Sinai School of Medicine.

The researchers said the results present a promising option for transplant patients and could be the basis for clinical trials in which patients are exposed to ultraviolet light before treatment.

"What we would do is try to eliminate the host Langerhans cells before the transplant, as we did in the mice," Merad said. She noted that dermatologists now use ultraviolet light to treat some skin diseases, administering it to patients inside a chamber under controlled circumstances to avoid burning.

Engleman said the ultraviolet treatment would have to be carefully administered to patients before bone marrow or stem cell transplantation to avoid harmful side effects. "The trick is deplete the host Langerhans cells in a manner that doesn’t cause other unwanted effects," he said.


Other Stanford researchers in the study include Petra Hoffman, PhD; Erik Ranheim, MD, PhD; Markus G. Manz, MD; Irving Weissman, MD; and Samuel Strober, MD. Other collaborators included Sarah Slaymaker and Israel Charo, MD, PhD, of UCSF; Sergio A. Lira, MD, PhD, of Mount Sinai; and Donald N. Cook, MD, of Duke University.

The study was funded by the National Institutes of Health and by a grant from the Irene Diamond Fund.

Stanford University Medical Center integrates research, medical education and patient care at its three institutions - Stanford University School of Medicine, Stanford Hospital & Clinics and Lucile Packard Children’s Hospital at Stanford. For more information, please visit the Web site of the medical center’s Office of Communication & Public Affairs at http://mednews.stanford.edu.

Ruthann Richter | EurekAlert!
Further information:
http://mednews.stanford.edu

More articles from Health and Medicine:

nachricht Research offers clues for improved influenza vaccine design
09.04.2018 | NIH/National Institute of Allergy and Infectious Diseases

nachricht Injecting gene cocktail into mouse pancreas leads to humanlike tumors
06.04.2018 | University of Texas Health Science Center at San Antonio

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Writing and deleting magnets with lasers

Study published in the journal ACS Applied Materials & Interfaces is the outcome of an international effort that included teams from Dresden and Berlin in Germany, and the US.

Scientists at the Helmholtz-Zentrum Dresden-Rossendorf (HZDR) together with colleagues from the Helmholtz-Zentrum Berlin (HZB) and the University of Virginia...

Im Focus: Gamma-ray flashes from plasma filaments

Novel highly efficient and brilliant gamma-ray source: Based on model calculations, physicists of the Max PIanck Institute for Nuclear Physics in Heidelberg propose a novel method for an efficient high-brilliance gamma-ray source. A giant collimated gamma-ray pulse is generated from the interaction of a dense ultra-relativistic electron beam with a thin solid conductor. Energetic gamma-rays are copiously produced as the electron beam splits into filaments while propagating across the conductor. The resulting gamma-ray energy and flux enable novel experiments in nuclear and fundamental physics.

The typical wavelength of light interacting with an object of the microcosm scales with the size of this object. For atoms, this ranges from visible light to...

Im Focus: Basel researchers succeed in cultivating cartilage from stem cells

Stable joint cartilage can be produced from adult stem cells originating from bone marrow. This is made possible by inducing specific molecular processes occurring during embryonic cartilage formation, as researchers from the University and University Hospital of Basel report in the scientific journal PNAS.

Certain mesenchymal stem/stromal cells from the bone marrow of adults are considered extremely promising for skeletal tissue regeneration. These adult stem...

Im Focus: Like a wedge in a hinge

Researchers lay groundwork to tailor drugs for new targets in cancer therapy

In the fight against cancer, scientists are developing new drugs to hit tumor cells at so far unused weak points. Such a “sore spot” is the protein complex...

Im Focus: The Future of Ultrafast Solid-State Physics

In an article that appears in the journal “Review of Modern Physics”, researchers at the Laboratory for Attosecond Physics (LAP) assess the current state of the field of ultrafast physics and consider its implications for future technologies.

Physicists can now control light in both time and space with hitherto unimagined precision. This is particularly true for the ability to generate ultrashort...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

IWOLIA: A conference bringing together German Industrie 4.0 and French Industrie du Futur

09.04.2018 | Event News

 
Latest News

Diamond-like carbon is formed differently to what was believed -- machine learning enables development of new model

19.04.2018 | Materials Sciences

Electromagnetic wizardry: Wireless power transfer enhanced by backward signal

19.04.2018 | Physics and Astronomy

Ultrafast electron oscillation and dephasing monitored by attosecond light source

19.04.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>